These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3492175

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.
    Binfiglio G, Stefani S, Nicoletti G.
    Chemotherapy; 1994; 40(5):311-6. PubMed ID: 7956454
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y, Watanabe Y, Sakamoto H, Hatano K, Kuno K, Higashi Y, Kamimura T, Matsumoto Y, Tawara S, Matsumoto F.
    J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC, Chin NX.
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [Abstract] [Full Text] [Related]

  • 8. Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391.
    Satake S, Hiraoka M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1989 Mar; 33(3):398-9. PubMed ID: 2658787
    [Abstract] [Full Text] [Related]

  • 9. The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.
    Neu HC, Chin NX, Labthavikul P.
    Infection; 1985 Mar; 13(3):146-55. PubMed ID: 3928497
    [Abstract] [Full Text] [Related]

  • 10. In vitro antibacterial activity and beta-lactamase stability of E-0702, a new cephalosporin.
    Neu HC, Labthavikul P.
    Antimicrob Agents Chemother; 1983 Sep; 24(3):313-20. PubMed ID: 6605718
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin.
    Chin NX, Gu JW, Fang W, Neu HC.
    Antimicrob Agents Chemother; 1991 Feb; 35(2):259-66. PubMed ID: 2024959
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.
    Hiraoka M, Masuyoshi S, Mitsuhashi S, Tomatsu K, Inoue M.
    J Antibiot (Tokyo); 1988 Jan; 41(1):86-93. PubMed ID: 3279015
    [Abstract] [Full Text] [Related]

  • 17. The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres.
    Reeves DS, Bywater MJ, Holt HA.
    J Antimicrob Chemother; 1993 Mar; 31(3):345-62. PubMed ID: 8486569
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro activity of cefpirome against selected clinical enterobacterial isolates with beta-lactamase-mediated resistance.
    Tzouvelekis LS, Tzelepi E, Mentis AF, Legakis NJ.
    Infection; 1995 Mar; 23(6):384-7. PubMed ID: 8655212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.